@article {26563,
	title = {Cardiac myosin activation with 2-deoxy-ATP via increased electrostatic interactions with actin},
	journal = {Proceedings of the National Academy of Sciences},
	year = {2019},
	month = {05/2019},
	publisher = {PNAS},
	abstract = {The naturally occurring nucleotide 2-deoxy-adenosine 5'-triphosphate (dATP) can be used by cardiac muscle as an alternative energy substrate for myosin chemomechanical activity. We and others have previously shown that dATP increases contractile force in normal hearts and models of depressed systolic function, but the structural basis of these effects has remained unresolved. In this work, we combine multiple techniques to provide structural and functional information at the angstrom-nanometer and millisecond time scales, demonstrating the ability to make both structural measurements and quantitative kinetic estimates of weak actin{\textendash}myosin interactions that underpin sarcomere dynamics. Exploiting dATP as a molecular probe, we assess how small changes in myosin structure translate to electrostatic-based changes in sarcomere function to augment contractility in cardiac muscle. Through Brownian dynamics simulation and computational structural analysis, we found that deoxy-hydrolysis products [2-deoxy-adenosine 5'-diphosphate (dADP) and inorganic phosphate (Pi)] bound to prepowerstroke myosin induce an allosteric restructuring of the actin-binding surface on myosin to increase the rate of cross-bridge formation. We then show experimentally that this predicted effect translates into increased electrostatic interactions between actin and cardiac myosin in vitro. Finally, using small-angle X-ray diffraction analysis of sarcomere structure, we demonstrate that the proposed increased electrostatic affinity of myosin for actin causes a disruption of the resting conformation of myosin motors, resulting in their repositioning toward the thin filament before activation. The dATP-mediated structural alterations in myosin reported here may provide insight into an improved criterion for the design or selection of small molecules to be developed as therapeutic agents to treat systolic dysfunction.},
	issn = {0027-8424},
	doi = {10.1073/pnas.1905028116},
	url = {http://www.pnas.org/lookup/doi/10.1073/pnas.1905028116https://syndication.highwire.org/content/doi/10.1073/pnas.1905028116},
	author = {Joseph D {Powers} and Yuan, Chen-Ching and Kimberly J {McCabe} and Jason D {Murray} and Matthew Carter {Childers} and Galina V {Flint} and Moussavi-Harami, Farid and Mohran, Saffie and Castillo, Romi and Zuzek, Carla and Ma, Weikang and Daggett, Valerie and Andrew D. {McCulloch} and Thomas C {Irving} and Regnier, Michael}
}
@article {26787,
	title = {Multiscale Models of Cardiac Muscle Biophysics and Tissue Remodeling in Hypertrophic Cardiomyopathies},
	journal = {Current Opinion in Biomedical Engineering},
	volume = {11},
	year = {2019},
	pages = {35-44},
	publisher = {Elsevier},
	doi = {https://doi.org/10.1016/j.cobme.2019.09.005},
	author = {Aboelkassem, Yasser and Joseph D {Powers} and Kimberly J {McCabe} and Andrew D. {McCulloch}}
}
